Deep Brain Stimulation Devices Pipeline Insight Market Research Report 2020 | Adaptive Neuromodulation, Bioinduction, Boston Scientific, Brainsway, Medtronic, NeuroOne Outlook, Product Types, Industry Dynamics, Pipeline Analysis, Future Perspectives
This reports provides a detailed study of the emerging DBS devices along with competitive landscape to help better understand the emerging DBS devices.
- Global coverage
Deep Brain Stimulation Devices Overview
Deep Brain Stimulation Devices: Understanding
The deep brain stimulation device is a battery-operated, surgically-implanted device. It is sometimes called a pacemaker for the brain. DBSs are commonly used to treat movement disorders as well as neuropsychiatric disorders. DBS is a therapy that relies on the delivery of mild electrical pulses to specific areas in the brain via an implanted lead connected to a battery-powered pulse generator placed in the patient’s upper chest area. A physician is able to vary and control the stimulation delivered through the lead to the brain using an external, hand-held programmer. At present, DBS systems use leads with electrodes that send out electrical current in all direction.
Who needs a deep brain stimulation device?
Patients with the following disorder:
- Essential tremor
- Obsessive-compulsive disorder
- Parkinsons disease
Request a Sample of Deep Brain Stimulation Devices Pipeline Insight Market Research Report @ https://martresearch.com/contact/request-sample/2/46037
Deep Brain Stimulation Devices Competitive Assessment
This segment of the deep brain stimulation devices pipeline report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including the latest news and press releases. The report also provides list of major players involved in the pipeline product development.
- Electrode Material
Two types of materials are used in the implementation of the electrodes: Brittle materials (e.g. Silicon) and ductile materials (e.g. metals and flexible polymers).
- Product Application
The DBS devices are used in Parkinson's disease, epilepsy, essential tremor, dystonia and obsessive compulsive disorder.
- Major Players in DBS Devices
There are approx. 20+ key companies which are developing the products for DBS devices.
- directSTIM DBS System: Aleva Neurotherapeutics SA.
Aleva’s revolutionary DBS system incorporates directional electrode technology and is designed to be more precise and efficient, with optimized stimulation that will potentially reduce side effects. At present, Aleva is the only emerging technology company to be awarded the CE-Mark for Deep Brain Stimulation.
- Picostim: Bioinduction Ltd
Picostim is in clinical trial phase. It is a miniaturized skull-mounted DBS device which is optimized to generate waveforms needed for stimulation of the subthalamic nucleus (STN) and STN region, employing a unique method of controlling stimulation current. The product undergoing clinical trial and is expected to be completed by 2023. It is a single center, open label, non-randomized design with the primary objective of showing similarity in control of motor symptoms for the Picostim device compared with previously published data for existing DBS devices.
Further product details are provided in the report…
Deep Brain Stimulation Devices Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.
The analysis is based on
- Brand Positioning of Leading companies
- Industry Collaborations
Deep Brain Stimulation Devices: Commercialization Activity
This segment of the report provides a detailed list of any commercial activity in the field of deep brain stimulator devices ranging from collaboration, mergers and acquisition, recent breakthrough among others.
- In August, 2020, the new Percept PC Neurostimulator with BrainSense developed by Medtronic was implanted to a patient in Penn State Health Milton S. Hershey Medical Center which become the first hospital in the state to implant a patient with a more personalized treatment for neurological disease
- Medtronic in August 2019 recalled the auto-registration feature of its StealthStation DBS software due to inaccuracies caused by minor patient movements during the auto-registration process when used with NexFrame stereotactic system during a DBS procedure. The problem resulted in 11 reports related to injuries and another 22 related to malfunctions, according to FDA.
Further commercial activities are provided in the report…...
Deep Brain Stimulation Devices: Reimbursement
US reimbursement policy, Medicare covers DBS for the treatment of essential tremor and/or Parkinsonian tremor. Medicare only consider DBS devices to be reasonable and necessary if they are Food and Drug Administration (FDA) approved devices devices used in accordance with FDA approved protocols governing Category B Investigational Device Exemption (IDE) DBS clinical trials.
Further information is provided in the report…...
Browse the Full Deep Brain Stimulation Devices Pipeline Insight Market Research Report @ https://martresearch.com/market-analysis/deep-brain-stimulation-devices-pipeline-insight/2/46037
- Extensive coverage of the DBS devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of DBS devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
- The report consists of in depth analysis of pipeline products based on various parameters
Deep Brain Stimulation Devices Report Insights
- Deep Brain Stimulation Devices - Pipeline Analysis
- Deep Brain Stimulation Devices - Unmet Need
- Deep Brain Stimulation Devices - Market Dynamics
- Deep Brain Stimulation Devices - Future Perspectives and Conclusion
- Deep Brain Stimulation Devices - Analyst Views
- What are significant companies in this segment, their information, analysis, and insights to improve R&D strategies?
- How to identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage?
- What are important and diverse types of DBS devices under development?
- What are market-entry and market expansion strategies in DBS devices?
- What are some of the mergers and acquisitions and to identify major players with the most promising pipeline?
- What is in-depth analysis of the product’s current stage of development, territory and estimated launch date?
- Adaptive Neuromodulation GmbH
- Adept Neuro SA
- Aleva Neurotherapeutics SA
- Bioinduction Limited
- Boston Scientific Corp
- Brainsway Ltd
- Cleveland Medical Devices Inc
- Cortera Neurotechnologies Inc
- Deep Brain Innovations, LLC
- Enspire DBS Therapy Inc
- Functional Neuromodulation Inc.
- Medtronic plc
- NeuroOne Inc
- Nexeon MedSystems Inc
- Wedge Therapeutics
Buy Full Deep Brain Stimulation Devices Pipeline Insight Market Research Report @ https://martresearch.com/paymentform/2/46037/Single_User
5708 Copper Creek Court Charlotte North Carolina 28227, USA
We, at MART RESEARCH value your time the most as we believe that time saved is directly proportional to profits earned. Before launching ourselves into this service, we did an extensive survey to understand the challenges clients face while gaining access to authentic data reports. The need of the hour was a common platform which could showcase published reports across a wide range of sectors. To overcome this limitation, we setup a repository which is a comprehensive one-stop shop for all your report requirements. It is user friendly, easy to browse, search and acquire reports which would fulfill your generalized as well as customized business needs.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deep Brain Stimulation Devices Pipeline Insight Market Research Report 2020 | Adaptive Neuromodulation, Bioinduction, Boston Scientific, Brainsway, Medtronic, NeuroOne Outlook, Product Types, Industry Dynamics, Pipeline Analysis, Future Perspectives here
News-ID: 2137776 • Views: 437
More Releases from Mart Research
Artificial Lung Devices Pipeline Insight Market Research Report 2020 | ALung Tec …
Artificial Lung Devices - Pipeline Insight and Competitive Landscape, 2020 report provides comprehensive insights about 20+ companies and 23+ pipeline devices in artificial lung devices pipeline landscape. Globally, number of cases related to respiratory failure and cardiopulmonary collapse has grown rapidly. This has resulted in increasing demand for artificial lung that acts as an external support system providing oxygenation of blood and removal of carbon dioxide from the blood. Researcher
Biopsy Devices Pipeline Insight Market Research Report 2020 | Outlook, Product T …
Biopsy Devices - Pipeline Insight and Competitive Landscape, 2020 report provides comprehensive insights about 20+ companies and 23+ pipeline devices in biopsy devices pipeline landscape. Significant increase in incidence of cancer, such as breast, prostate, and lung, and rapid technological advancements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies fuel the adoption of biopsy devices. Moreover, rise in awareness on diagnosis of chronic diseases fosters the demand for
Coronary Stents Pipeline Insight Market Research Report 2020 | REVA Medical, Ron …
Coronary Stents - Pipeline Insight and Competitive Landscape, 2020 report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Coronary Stents pipeline landscape. Owing to the rise in the prevalence of coronary artery diseases (CAD), the coronary stents market is witnessing remarkable growth. Significant players are focusing on expanding their geographical reach, for dominating the current market. According to the Centre for Disease Control and Prevention, about one-third
Vascular Grafts Pipeline Insight Market Research Report 2020 | RegenaGraft, Huma …
Vascular Grafts - Pipeline Insight and Competitive Landscape, 2020 report provides comprehensive insights about 20+ companies and 25+ pipeline devices in Vascular Grafts pipeline landscape. Heart disease has been the world's biggest cause of mortality, with this trend forecast to continue into the near future. Common disorders contribute to blood vessel stenosis or occlusion. Surgeries using vascular grafts such as coronary artery bypass grafting and peripheral artery bypass grafting is
More Releases for DBS
DBS Wealth Management Market 2019: Business Planning Research Analysis by DBS, …
DBS Group is a financial services company with a presence in 18 markets. It has four main business segments and offers wealth management services through its Consumer Banking/Wealth Management (CBWM) unit. The wealth business is further divided into three tiered propositions, with a focus on Asia. Get Sample Copy of This Report at@ https://www.orbisresearch.com/contacts/request-sample/2663614 This competitor profile provides a comprehensive analysis of DBS's wealth operations. It offers insight into the company’s strategy
DBS Bank: Key Strategies and Innovations to Witness Growth
DBS appointed Neal Cross as chief innovation officer. He is responsible for driving the banks digital innovation agenda across Asia. The bank has also partnered with various government-backed venture capital firms, non-profit organizations, and technology providers to help its SME and other corporate customers find digital solutions as per their business needs. Such factors that have been influencing growth of DBS bank have been included in a report titled “DBS
DBS Bank Fintech Ecosystem Market Innovation Initiatives and Strategy by Carouse …
In 2014, DBS appointed Neal Cross as chief innovation officer. He is responsible for driving the bank’s digital innovation agenda across Asia. In the same year, DBS committed S$200m to build a digital infrastructure for the bank, leveraging big data, biometrics, and artificial intelligence (AI) technologies. DBS Bank established a developer team to create APIs and launch the world’s largest API platform. The bank has also partnered with various government-backed venture
FinTrack Market Is Booming Worldwide| Paytm, SkyWatch, Barclays, DBS Bank
HTF Market Intelligence released a new research report of 19 pages on title 'FinTrack Market 2018’ with detailed analysis, forecast and strategies. The study covers key regions that includes North America, Europe or Asia and important players such as Stripe, AgeWage, Barclays, Umpqua Bank, DBS Bank, Aberdeen Standard Investments, Paytm, SkyWatch, Homelyfe Request a sample report @ https://www.htfmarketreport.com/sample-report/1399361-fintrack-september-2018 Summary Every month, FinTrack will showcase the latest innovations from financial providers around the
Deep Brain Stimulation Devices Market Analysis On the basis of Products such as …
Deep Brain Stimulation is a neosurgical system which treats an assortment of devastating neurological responses. It joins the implantation of a battery-worked restorative gadget called Neurostimulator. Neurostimulation development can improve the life idea of the people who are truly stifled or encountering critical mishaps to various sense organs, and also to last decline of outrageous, unending torment which would somehow require unfaltering (day and night), high-measurements opioid treatment, (for instance,
DBS Central’s Optimised DBS Check Systems Deliver 1-Hour Processing
London, United Kingdom, Tuesday, August 30th, 2016 The DBS Central agency’s streamlined online platform has formally announced that it is capable of delivering DBS check processing times of just one hour. Today, DBS Central, a leading Disclosure and Barring Service, DBS provider in the United Kingdom for individuals and companies, has confirmed that its faster and more user-friendly online portal has tracked an impressive processing turnaround time of just one hour. From the